Literature DB >> 13377617

[Tests of ceruloplasmin substitution in hepatocerebral degeneration (Wilson's disease)].

H BICKEL, I GOLLNER, W GRUTER, H E SCHULTZE.   

Abstract

Entities:  

Keywords:  COPPER/in blood; HEPATOLENTICULAR DEGENERATION/therapy

Mesh：

Substances：

Year:  1956        PMID： 13377617     DOI： 10.1007/bf01473248

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  21 in total

1.  Metabolic studies in Wilson's disease using Cu64.

Authors:  A G BEARN; H G KUNKEL
Journal:  J Lab Clin Med       Date:  1955-04

2.  [Paper chromatography in pediatrics].

Authors:  H BICKEL; F SOUCHON
Journal:  Arch Kinderheilkd Suppl       Date:  1955

3.  Studies on copper metabolism. XIII. Hepatolenticular degeneration.

Authors:  G E CARTWRIGHT; R E HODGES; C J GUBLER; J P MAHONEY; K DAUM; M M WINTROBE; W B BEAN
Journal:  J Clin Invest       Date:  1954-11       Impact factor: 14.808

4.  Localization of Cu64 in serum fractions following oral administration: an alteration in Wilson's disease.

Authors:  A G BEARN; H G KUNKEL
Journal:  Proc Soc Exp Biol Med       Date:  1954-01

5.  The amino acid content of the blood and urine in Wilson's disease.

Authors:  W H STEIN; A G BEARN; S MOORE
Journal:  J Clin Invest       Date:  1954-03       Impact factor: 14.808

6.  Amino-aciduria in lead poisoning; a case in childhood.

Authors:  V K WILSON; M L THOMSON; C E DENT
Journal:  Lancet       Date:  1953-07-11       Impact factor: 79.321

7.  Micro-determination of copper in biological material.

Authors:  A Eden; H H Green
Journal:  Biochem J       Date:  1940-09       Impact factor: 3.857

8.  Immunological and electrophoretic studies on human gamma-globulins.

Authors:  B V JAGER; E L SMITH
Journal:  J Biol Chem       Date:  1948-12       Impact factor: 5.157

9.  Oxidase reactions in human plasma caused by coeruloplasmin.

Authors:  C G HOLMBERG; C B LAURELL
Journal:  Scand J Clin Lab Invest       Date:  1951       Impact factor: 1.713

10.  Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.

Authors:  H MARKOWITZ; C J GUBLER; J P MAHONEY; G E CARTWRIGHT; M M WINTROBE
Journal:  J Clin Invest       Date:  1955-10       Impact factor: 14.808
View more
  7 in total

1.  [A CONTRIBUTION TO WILSON'S DISEASE FROM A CLINICAL AND MORPHOLOGICAL VIEWPOINT].

Authors:  R SCHEDIFKA; A TENNSTEDT
Journal:  Dtsch Z Nervenheilkd       Date:  1964-07-06

2.  [A histochemical contribution to metal deposition in the Kayser--Fleischer corneal ring].

Authors:  R SCHNABEL; G NISCH
Journal:  Albrecht Von Graefes Arch Ophthalmol       Date:  1961

3.  The treatment of hepatolenticular degeneration.

Authors:  J N CUMINGS
Journal:  Proc R Soc Med       Date:  1959-01

4.  Discussion on some clinical, genetic and biochemical aspects of metabolic disorders of the nervous system: metabolic disease of the nervous system: clinical aspects.

Authors:  W B MATTHEWS
Journal:  Proc R Soc Med       Date:  1958-10

5.  Observations on ceruloplasmin in Wilson's disease.

Authors:  A SASS-KORTSAK; M CHERNIAK; D W GEIGER; R J SLATER
Journal:  J Clin Invest       Date:  1959-10       Impact factor: 14.808

6.  Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.

Authors:  I H SCHEINBERG; A G MORELL
Journal:  J Clin Invest       Date:  1957-08       Impact factor: 14.808

7.  [Hemolytic crises as an early manifestation of Wilson's disease. A contribution to the pathogenesis of hepatocerebral degeneration].

Authors:  W GRUETER
Journal:  Dtsch Z Nervenheilkd       Date:  1959
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.